Parnax Lab

Parnax Lab Gross Margin

The Gross Margin of Parnax Lab (506128.BO) as of Nov 18, 2026 is 45.71 %. In the previous year, Gross Margin was 45.52 % — a change of 0.41% (higher).

Gross Margin

45.71 %

YoY

0.41%

Last updated:

Gross Margin of Parnax Lab is 2025 45.71 % . Gross Margin of Parnax Lab was 2024 45.52 % . It decreases by 0.41% higher compared to the previous year.

For Parnax Lab, the gross margin of 45.7% is down versus 53.6% a few years ago.

The Parnax Lab Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
47.96 INR
Jan 1, 2019
51.54 INR
Jan 1, 2020
52.50 INR
Jan 1, 2021
53.63 INR
Jan 1, 2022
45.01 INR
Jan 1, 2023
46.52 INR
Jan 1, 2024
45.52 INR
Jan 1, 2025
45.71 INR
The Parnax Lab Gross Margin history
YEARGross MarginYoY
45.71 %+0.41%
45.52 %-2.14%
46.52 %+3.33%
45.01 %-16.07%
53.63 %+2.15%
52.50 %+1.87%
51.54 %+7.46%
47.96 %+7.26%
44.72 %+1.05%
44.25 %+31.96%
33.54 %+18.38%
28.33 %+6,620.49%
0.42 %+136.46%
0.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

Gross Margin of Parnax Lab is 45.71 % in 2025.

Gross Margin of Parnax Lab changed from 45.52 % to 45.71 %, representing a 0.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Parnax Lab with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Parnax Lab

All Key Metrics — Parnax Lab